Neurocrine Biosciences NBIX Total costs & expenses

Total costs & expenses at other companies

Bristol-Myers SquibbBMY

$8.89B-15.3%

Acadia PharmaceuticalsACAD

$270.12M+16.3%

Crinetics PharmaceuticalsCRNX

$151.11M+35.2%

BridgeBio PharmaBBIO

$300.47M+36.0%

BiogenBIIB

$2.6B+36.9%

Rhythm Pharmaceuticals, Inc.RYTM

$112.47M+41.1%

FAQ

What is Neurocrine Biosciences's total costs & expenses?

Neurocrine Biosciences (NBIX) reported total costs & expenses of $621.1M in Q1 2026.

How has Neurocrine Biosciences's total costs & expenses changed year-over-year?

Neurocrine Biosciences's total costs & expenses increased by 13.1% year-over-year, from $549M to $621.1M.

What is the long-term trend for Neurocrine Biosciences's total costs & expenses?

Over 4 years (2021 to 2025), Neurocrine Biosciences's total costs & expenses has grown at a 21.4% compound annual growth rate (CAGR), from $1.03B to $2.24B.

What does total costs & expenses mean?

This metric aggregates all operating costs, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the total resources consumed to maintain business operations and support clinical development programs. Monitoring this figure helps assess the company's overall operational efficiency and cost control discipline.